Interestingly, in HFD-fed mice, p53-null mice exhibited the attenuation of hepatic steatosis and lipid and TG accumulation as well as lower insulin and improved ITT/GTT performance compared with wild-type mice (Fig. 3a–e). This evidence concerns the gene INS and Hepatic steatosis.